News
Videos
Conferences
Events
Resources
Subscribe

|Videos|December 1, 2020

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Author(s)Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of Lung cancer

5 Years of Lung Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

ByQuincy Attobrah

September 11th 2026

Miguel Gonzales-Velez

Placebos in Cancer Clinical Trials: What Patients Need to Know

ByDr. Miguel Gonzalez-Velez,Kaitlyn M. Le

September 9th 2026

Image of FDA

FDA Grants Accelerated Approval to Hyrnuo for Certain Patients With HER2-Mutated NSCLC

ByQuincy Attobrah

September 9th 2026

Medicare Ostomy Supply Changes Could Affect Cancer Survivors

Medicare Ostomy Supply Changes Could Affect Cancer Survivors

ByDr. Diego Schaps ,Kaitlyn M. Le

September 8th 2026

image of man.

How Pediatric Oncology is Shifting Toward Reducing Long-Term Side Effects

ByDr. Doured Daghistani

September 5th 2026

Trending on CURE

5 Years of Prostate Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

5 Years of Lung Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients

FDA Grants Final Approval to OMCAZIO, a New Capsule Formulation of Cabozantinib

What Your Friend with Cancer REALLY Needs

Cancer Drug Shortages Show Little Improvement in Fourth Year, New NCCN Survey Finds